C. Difficile Toxin Gene Amplification Assay

Home/Specialty/Microbiology/C. Difficile Toxin Gene Amplification Assay

C. Difficile Toxin Gene Amplification Assay

Main Filters

C. Difficile Toxin Gene Amplification Assay

BECTON, DICKINSON AND COMPANY
CATALOG #	QTY	PRICE	DESCRIPTION
443418	0	-	Kit BD MAX Cdiff USA

DIAGNOSTIC HYBRIDS, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
M307	0	-	Solana C. difficile Assay

DIASORIN MOLECULAR LLC
CATALOG #	QTY	PRICE	DESCRIPTION
MOL2950	0	-
MOL2960	0	-
MOL5290	0	-

GenePoc Inc
CATALOG #	QTY	PRICE	DESCRIPTION
132994	0	-	The GenePOC™ CDiff assay performed on the revogene™ instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The GenePOC CDiff assay is intended to aid in the diagnosis of CDI.

GREAT BASIN SCIENTIFIC, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
GBCDIFF-10	0	-	C. diff Assay Cartridge and Sample Prep Device.

LUMINEX CORPORATION
CATALOG #	QTY	PRICE	DESCRIPTION
20-006-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
20-009-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
20-011-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
30-002-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
50-10018	0	-	The ARIES® C. difficile Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of Clostridium difficile (C. difficile) nucleic acid in unformed (liquid or soft) stool specimens obtained from patients suspected of having Clostridium difficile infection (CDI).

Meridian Bioscience Canada Inc
CATALOG #	QTY	PRICE	DESCRIPTION
410300	0	-	The Revogene® C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.

MERIDIAN BIOSCIENCE, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
401300	0	-	The Revogene C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection. The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.

NANOSPHERE, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
20-006-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
20-009-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
20-011-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
30-002-022	0	-	The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).

QIAGEN GmbH
CATALOG #	QTY	PRICE	DESCRIPTION
4572346	0	-

QUIDEL CORPORATION
CATALOG #	QTY	PRICE	DESCRIPTION
M105	0	-	Lyra Direct CDIFF Assay
M201	0	-	AmpliVue CDiff Assay

21 Results

Results Per Page

Catalog #

Available

Starting At

Name

Company Name

Description

GBCDIFF-10

Portrait Toxigenic C. difficile Assay

GREAT BASIN SCIENTIFIC, INC.

C. diff Assay Cartridge and Sample Prep Device.

M307

Solana

DIAGNOSTIC HYBRIDS, INC.

Solana C. difficile Assay

M201

AmpliVue

QUIDEL CORPORATION

AmpliVue CDiff Assay

M105

Lyra

QUIDEL CORPORATION

Lyra Direct CDIFF Assay

MOL5290

Simplexa™ C.difficile Sample Prep Kit

DIASORIN MOLECULAR LLC

MOL2960

Simplexa™ C. difficile Positive Control Pack

DIASORIN MOLECULAR LLC

MOL2950

Simplexa™ C. difficile Direct

DIASORIN MOLECULAR LLC

4572346

artus® C. difficile QS-RGQ MDx Kit

QIAGEN GmbH

30-002-022

Clostridium difficile (CDF) Stool Sample Preparation Kit

NANOSPHERE, INC.

The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).

20-011-022

Clostridium difficile (CDF) Amplification Tray

NANOSPHERE, INC.

20-009-022

Clostridium difficile (CDF) Extraction Tray

NANOSPHERE, INC.

20-006-022

Clostridium difficile (CDF) Nucleic Acid Test Cartridge

NANOSPHERE, INC.

401300

Revogene C. difficile

MERIDIAN BIOSCIENCE, INC.

The Revogene C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection. The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.

30-002-022

Clostridium difficile (CDF) Stool Sample Preparation Kit

LUMINEX CORPORATION

20-011-022

Clostridium difficile (CDF) Amplification Tray

LUMINEX CORPORATION

20-009-022

Clostridium difficile (CDF) Extraction Tray

LUMINEX CORPORATION

20-006-022

Clostridium difficile (CDF) Nucleic Acid Test Cartridge

LUMINEX CORPORATION

50-10018

ARIES® C. difficile Assay

LUMINEX CORPORATION

The ARIES® C. difficile Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of Clostridium difficile (C. difficile) nucleic acid in unformed (liquid or soft) stool specimens obtained from patients suspected of having Clostridium difficile infection (CDI).

410300

Revogene® C. difficile

Meridian Bioscience Canada Inc

The Revogene® C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.

132994

GenePOC™ CDiff

GenePoc Inc

The GenePOC™ CDiff assay performed on the revogene™ instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The GenePOC CDiff assay is intended to aid in the diagnosis of CDI.

443418

BD MAX™ Cdiff (US)

BECTON, DICKINSON AND COMPANY

Kit BD MAX Cdiff USA